Overview
- A large multicenter analysis of more than 550,000 platelet and plasma transfusions reported a pattern of allergic reactions concentrated in U.S. sites with high alpha‑gal prevalence, especially in type O recipients of B or AB donor units.
- Dartmouth Hitchcock Medical Center has already stopped giving B or AB platelets to O-group patients in response to the study’s findings, signaling an immediate change in transfusion practice in at least one hospital.
- Martha’s Vineyard Hospital launched a prospective two‑year study to enroll up to 300 island residents who were bitten by lone star ticks to measure how often alpha‑gal syndrome develops and to search for immune or inflammatory biomarkers that predict risk.
- Alpha‑gal syndrome is an allergy to a mammalian sugar molecule transmitted by certain ticks that can cause delayed hives, gastrointestinal symptoms, breathing problems, or anaphylaxis and complicates both diagnosis and safe use of blood products.
- Public health actions are expanding as evidence mounts: Massachusetts made alpha‑gal reportable and adjusted deer management, and clinicians and blood banks in high‑prevalence regions are revising screening, matching and surveillance while researchers pursue prevention and treatment options.